Chapter 4: Percutaneous delivery of cyclizine and its alkyl analogues
140
120
100
40
20
o
II
III
IV
Compound
FIGURE4-1: Melting points of (I) and its alkylanalogues.
68 - - - --
-080
-
c
.-
0c.
en
c
60
.-
-G)
:i
Chapter 4: Percutaneous delivery of cyclizine and its alkyl analogues
700
600
500
-E
-
C) :::1.~400
-:s
:s '0 U)~ 300
o
CD :scr
«
200
100
o
591.4II
III
IV
Compound
FIGURE 4-2: Aqueous solubilities of (I) and its alkyl analogues at 32 DC.
Chapter 4: Percutaneous delivery of cyclizine and its alkyl analogues
Log Kp
-4
FIGURE4-3: Permeability (log kp) and partition coefficients (log Koct)of (I) and its alkyl analogues.
70
--6
y
=
R2O.514x+ 2.6151=
0.9988 Log KoctI
-5
-1:)4
-
..
c Q) 'uis
3 Q) 0 u c 0:e 2
1:: as Q, CI .2 1 c as-0
-
I
I
I
-
I
i
II
I
I
III I
I IV
E -1 2i as Q)E -2
Q) Q, CI 0 ...I-3
Chapter4: Percutaneous delivery of cyclizine and its alkylanalogues
9
8
7
6.95226
3
2
1
0.6864 0.1818o
II
III
IV
Compound
FIGURE4-4:
Mean steady-stateflux
:t SD of (I) and its alkyl analogues from saturated aqueous solutions(n = 6).Chapter 4: Percutaneous delivery of cyclizine and its alkyl analogues
FIGURE